Clinical Trials

200 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT02893332 2021-02-03

Sindas

Phase 3 Terminated

200 enrolled

Stage IV EGFR Mutated Non-Small Cell Lung Cancer

NCT00402779 2020-04-21

Erlotinib Prevention of Oral Cancer (EPOC)

303 enrolled 11 charts

Head & Neck

Carcinoma in Situ, Mouth Neoplasms

NCT00153803 2019-09-06

Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

245 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT00300586 2019-05-28

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

842 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02775006 2019-04-30

Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma

Phase 3 Terminated

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02178397 2017-07-17

FLARE

Phase 3 Terminated

6 enrolled

Lung Neoplasms

NCT02795884 2016-12-30

Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation

Phase 3 Withdrawn

Lung Neoplasms

NCT01887795 2016-08-25

Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as ﬁrst-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study

224 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00265824 2015-12-11

DREAM

700 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00634725 2015-12-11

Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

820 enrolled

Pancreatic Neoplasms

NCT01229813 2015-04-13

ACT2

233 enrolled

Colorectal Neoplasms

NCT02140333 2015-02-12

Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC

220 enrolled

NSCLC

NCT00275132 2014-12-03

TOPICAL

670 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00874419 2014-09-25

ML20981

165 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00686114 2014-04-29

Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer

344 enrolled

Esophageal Neoplasms

NCT02001896 2013-12-05

Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00598156 2013-04-22

ACT

249 enrolled

Colorectal Neoplasms

NCT00440167 2012-07-09

Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine

280 enrolled

Pancreatic Neoplasms

NCT00637910 2012-02-24

TAILOR

850 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00440414 2010-08-19

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

320 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01158170 2010-07-08

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)